Загрузка...
ADMA, SDMA and L-arginine may be Novel Targets in Pharmacotherapy for Complications due to Cardiopulmonary Bypass
BACKGROUND: In this study, the effects of olmesartan therapy on asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), L-arginine and inducible nitric oxide synthase (iNOS) levels were investigated in patients undergoing cardiopulmonary bypass. METHODS: Patients were randomly allocat...
Сохранить в:
| Опубликовано в: : | J Med Biochem |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Society of Medical Biochemists of Serbia
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5471654/ https://ncbi.nlm.nih.gov/pubmed/28680344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jomb-2016-0025 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|